EGFR and central nervous system cancer: In IDH1/2-wild-type gliomas, high frequencies of TERTp mutations (48.9%), EGFR amplifications (29.7%), PTEN alterations (27.9%), and chromosomal 7+/10− alterations (27.5%) correlated with advanced age and poor prognosis (Fig. 3F).